Helius Medical Technologies, Inc. (NASDAQ:HSDT) Short Interest Down 75.0% in March

Helius Medical Technologies, Inc. (NASDAQ:HSDT) was the recipient of a significant decrease in short interest in March. As of March 31st, there was short interest totalling 16,600 shares, a decrease of 75.0% from the March 15th total of 66,300 shares. Based on an average daily volume of 2,420,000 shares, the short-interest ratio is currently 0.0 days. Approximately 0.5% of the company’s stock are sold short.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Helius Medical Technologies stock. Virtu Financial LLC acquired a new position in shares of Helius Medical Technologies, Inc. (NASDAQ:HSDT) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 46,510 shares of the company’s stock, valued at approximately $31,000. Virtu Financial LLC owned 1.25% of Helius Medical Technologies as of its most recent SEC filing. Hedge funds and other institutional investors own 18.63% of the company’s stock.

Helius Medical Technologies Stock Down 3.4 %

Shares of NASDAQ:HSDT traded down $0.01 during trading on Wednesday, reaching $0.28. The stock had a trading volume of 27,118 shares, compared to its average volume of 1,379,587. The firm has a market capitalization of $1.72 million, a price-to-earnings ratio of -0.05 and a beta of 1.27. Helius Medical Technologies has a 52 week low of $0.27 and a 52 week high of $5.33. The stock has a fifty day simple moving average of $0.44 and a two-hundred day simple moving average of $0.55.

Helius Medical Technologies (NASDAQ:HSDT) last announced its quarterly earnings data on Tuesday, March 25th. The company reported ($1.03) EPS for the quarter, missing analysts’ consensus estimates of ($0.94) by ($0.09). Helius Medical Technologies had a negative net margin of 1,764.74% and a negative return on equity of 244.82%. The company had revenue of $0.15 million for the quarter, compared to analyst estimates of $0.10 million.

Helius Medical Technologies Company Profile

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.